gallstones/glavobol

Povezava se shrani v odložišče

Izberite vrsto razvrščanja

Stran 1 iz 19 rezultatov

[The 452th case: rash, hypotension, abdominal pain and headache].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized with multiple organ involvements. Acute acalculous cholecystitis(AAC) is an extremely rare manifestation of digestive system involvement in SLE. We reported a case of 32-year-old woman who complained skin rashes for two weeks

[Headache, fever and upper abdominal colic].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

A nine year old boy who had received Ceftriaxone for one week because of suspected bacterial meningoencephalitis developed colicky abdominal pain in the right upper quadrant two days after termination of Ceftriaxone treatment. Stones in the gallbladder were identified as cause of the abdominal

Proceedings of the discussion, "Tolerability and safety of Sandostatin".

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Side effects of octreotide may be local, biochemical, gastroenterological, or endocrinological. Local pain at the injection site occurs frequently, but rarely lasts more than 15 minutes and often resolves with continued therapy and may be improved if the vial is warmed prior to injection. No

Non-steroid anti-inflammatory drugs for biliary colic.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Cholelithiasis refers to the presence of gallstones, which are concretions that form in the biliary tract, usually in the gallbladder. Cholelithiasis is one of the most common surgical problems worldwide and is particularly prevalent in most Western countries.Biliary colic is the term

Clinical results of long-term slow-release lanreotide treatment of acromegaly.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Medical therapy is frequently needed to normalize growth hormone/insulin-like growth factor I secretion in acromegaly. The aim of this study was to determine the long-term effects of the slow-release (SR) somatostatin analogue lanreotide in 57 acromegalic patients. SR lanreotide (30 mg) was given

[Effects of cholecystectomy on functional signs associated with cholelithiasis].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Two hundred hospital patients with gallstones who had been cholecystectomized on account of typical biliary colics were investigated for migraine, headache, malaise, vertigo, flatulence, diarrhoea or constipation 2, 6, 12 and 24 months after the operation. The study showed that these symptoms are

Chronic non-organic upper abdominal pain: diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5- to 7-year follow-up study.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

To establish the diagnostic safety and the prognosis in outpatients with non-organic upper abdominal pain, 37 patients were followed up 5-7 years after the index investigation. In only one case had the diagnosis been changed during the follow-up period. This was in a man who erroneously had not been

GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

New depot somatostatin analogs such as lanreotide-slow release (LAN) represent a significant improvement in the medical treatment of acromegaly. Seventy-three consecutive acromegalic patients, treated by LAN, were evaluated in a retrospective monocentric study. Sixteen were excluded from further

Helicobacter pylori infection in patients with calcular cholecystitis: a hospital based study.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Helicobacter pylori, a gram negative bacillus has been recognised as a public health problem and approximately half of the world population has H. pylori infection causes chronic gastritis, peptic ulcer disease and gastric malignancies. Objective of this study was to determine the

Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

This single-center open sequential study aimed at comparing the efficacy of a 6-month treatment with lanreotide (LAN) (60-90 mg/month i.m.), to that of octreotide (OCT) (0.3-0.6 mg/day s.c.) in 45 patients with active acromegaly (GH, 63.2+/-12.1 ng/ml, IGF-I, 757+/-67.1 ng/ml). After 6 months of OCT

Clinical and biochemical effects of incremental doses of the long-acting somatostatin analogue SMS 201-995 in ten acromegalic patients.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Ten patients (seven women, three men) with active acromegaly, five previously treated and five newly diagnosed, were included in an open-label prospective trial of 3 daily subcutaneous injections of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) at increasing doses in order to

The role of Sandostatin in acromegaly.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Long-acting somatostatin analogues are extensively used for the treatment of acromegalic patients who have not been cured by surgery or for whom surgery is contraindicated or hazardous. Such an analogue, Sandostatin, has been approved for this indication in various countries and to date an overall

Prolonged therapy of chronic hepatitis C with ribavirin.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Therapy with ribavirin for 6-12 months is associated with decreases in serum aminotransferases in some patients with chronic hepatitis C. We have assessed the practicality and safety of prolonged therapy with ribavirin. Six patients with chronic hepatitis C were given 1000-1200 mg of ribavirin daily

Review of European clinical experience with fenofibrate.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Since the introduction of fenofibrate to European clinical practice in 1975, some 6.5 million patient-years of experience in the treatment of hyperlipidemia have been accumulated. A review of results of clinical trials shows fenofibrate to have a broad spectrum of lipid-lowering activity, reducing

[The adrenocortical carcinoma, a tumour of wide clinical diversity].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Over the course of a few years, an obese 52-year-old woman with a 23-year history of hypertension developed a number of abdominal complaints including gall stones. Her blood pressure became increasingly difficult to control and she developed diabetes mellitus and suffered palpitations and headaches.

Prejšnji
1
2
Naslednji

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah